ORF_ID	CONTIG	START	STOP	ORIENTATION	CUT_OFF	PASS_EVALUE	Best_Hit_evalue	Best_Hit_ARO	Best_Identities	ARO	ARO_name	Model_type	SNP	Best_Hit_ARO_category	ARO_category	PASS_bitscore	Best_Hit_bitscore	bit_score	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	LABEL	ID	Model_id
BGC0000879.1|Toyocamycin/sangivamycin_5	ID=1_5;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.704	4966	5478	+	Loose	n/a	0.513957	OXA-357	30.19	ARO:3001639, ARO:3001686, ARO:3001539, ARO:3001480, ARO:3001669, ARO:3002498, ARO:3001660, ARO:3001443, ARO:3001646, ARO:3001653, ARO:3001564, ARO:3001650, ARO:3001668, ARO:3001577, ARO:3001571, ARO:3001642, ARO:3001636, ARO:3001673, ARO:3001544, ARO:3001655, ARO:3001574, ARO:3001627, ARO:3001664, ARO:3001570, ARO:3001562, ARO:3001622, ARO:3003147, ARO:3001612, ARO:3002500, ARO:3001648, ARO:3001649, ARO:3001575, ARO:3001674, ARO:3001613, ARO:3001633, ARO:3002506, ARO:3003770, ARO:3001656, ARO:3001516, ARO:3001629, ARO:3001441, ARO:3002501, ARO:3001644, ARO:3001563, ARO:3001652, ARO:3001680, ARO:3001576, ARO:3001566, ARO:3001619, ARO:3001486, ARO:3001634, ARO:3001621, ARO:3001703, ARO:3001675, ARO:3001628, ARO:3001484, ARO:3001665, ARO:3001513, ARO:3002508, ARO:3001472, ARO:3001557, ARO:3002859, ARO:3001565, ARO:3001658, ARO:3001688, ARO:3001438, ARO:3000413, ARO:3001641, ARO:3001437, ARO:3001617, ARO:3001536, ARO:3001526, ARO:3002497, ARO:3001637, ARO:3002505, ARO:3001687, ARO:3002959, ARO:3001616, ARO:3001482, ARO:3001640, ARO:3001552, ARO:3001518, ARO:3001488, ARO:3002502, ARO:3001442, ARO:3002509, ARO:3000410, ARO:3001672, ARO:3001537, ARO:3001651, ARO:3001545, ARO:3001512, ARO:3001568, ARO:3001572, ARO:3001643, ARO:3001560, ARO:3001511, ARO:3001635, ARO:3001541, ARO:3001661, ARO:3001626, ARO:3001519, ARO:3001632, ARO:3001683, ARO:3001569, ARO:3001510, ARO:3001684, ARO:3001453, ARO:3001620, ARO:3001615, ARO:3001479, ARO:3001712, ARO:3001667, ARO:3001535, ARO:3002507, ARO:3001623, ARO:3001682, ARO:3001638, ARO:3001630, ARO:3001624, ARO:3001540, ARO:3001573, ARO:3001685, ARO:3001538, ARO:3001440, ARO:3001625, ARO:3001657, ARO:3001645, ARO:3001474, ARO:3001489, ARO:3001520, ARO:3001618, ARO:3001515, ARO:3001454, ARO:3001473, ARO:3001689, ARO:3001567, ARO:3001455, ARO:3002480, ARO:3001704, ARO:3001614, ARO:3001666, ARO:3003148, ARO:3001546	OXA-176, OXA-177, OXA-174, OXA-172, OXA-173, OXA-178, OXA-179, OXA-208, OXA-93, OXA-90, OXA-91, OXA-323, OXA-322, OXA-94, OXA-95, OXA-200, OXA-201, OXA-98, OXA-99, OXA-206, OXA-328, OXA-100, OXA-107, OXA-106, OXA-104, OXA-109, OXA-108, OXA-84, OXA-87, OXA-80, OXA-83, OXA-82, OXA-330, OXA-331, OXA-332, OXA-86, OXA-89, OXA-88, OXA-148, OXA-338, OXA-180, dfrA14, OXA-110, OXA-111, OXA-112, OXA-113, OXA-115, OXA-116, OXA-117, OXA-223, OXA-380, OXA-383, OXA-382, OXA-385, OXA-384, OXA-387, OXA-386, OXA-425, OXA-391, OXA-194, OXA-195, OXA-197, OXA-92, OXA-390, OXA-51, OXA-325, OXA-324, OXA-128, OXA-121, OXA-120, OXA-254, OXA-253, OXA-250, OXA-316, OXA-317, OXA-314, OXA-315, OXA-312, OXA-313, OXA-202, PDC-10, OXA-203, OXA-217, OXA-138, OXA-132, OXA-130, OXA-131, OXA-242, OXA-248, OXA-249, OXA-365, OXA-70, OXA-71, OXA-75, OXA-76, OXA-77, OXA-78, OXA-79, OXA-219, OXA-378, OXA-379, OXA-149, OXA-388, OXA-371, OXA-144, OXA-374, OXA-376, OXA-377, OXA-424, Listeria monocytogenes mprF, OXA-69, OXA-68, OXA-67, OXA-66, OXA-65, OXA-64, PDC-8, OXA-381, OXA-349, OXA-348, OXA-150, OXA-327, sul1, sul3, OXA-352, OXA-353, OXA-350, OXA-351, OXA-357, OXA-354, OXA-358, OXA-359, PDC-5, PDC-4, PDC-7, PDC-6, PDC-1, PDC-3, PDC-2, OXA-213, PDC-9, OXA-216, OXA-389, vanYG1	protein homolog model	n/a	antibiotic inactivation enzyme; determinant of beta-lactam resistance	antibiotic inactivation enzyme; antibiotic resistance gene cluster, cassette, or operon; antibiotic target modifying enzyme; antibiotic target replacement protein; determinant of beta-lactam resistance; determinant of diaminopyrimidine resistance; determinant of resistance to glycopeptide antibiotics; determinant of resistance to peptide antibiotics; determinant of sulfonamide resistance; gene altering cell wall charge; protein(s) conferring antibiotic resistance via molecular bypass	500	26.5646	26.1794, 26.1794, 26.1794, 23.0978, 25.7942, 24.6386, 23.0978, 25.7942, 26.1794, 25.7942, 23.8682, 26.1794, 25.7942, 24.6386, 26.1794, 26.1794, 26.1794, 24.2534, 26.5646, 23.0978, 23.0978, 26.1794, 25.7942, 26.1794, 25.7942, 26.1794, 26.1794, 25.7942, 24.6386, 25.409, 25.0238, 25.7942, 26.1794, 25.0238, 23.483, 24.6386, 25.409, 23.0978, 23.483, 26.1794, 24.6386, 24.6386, 26.1794, 27.335, 23.0978, 25.7942, 23.0978, 24.2534, 26.1794, 24.2534, 23.0978, 23.0978, 25.7942, 24.2534, 26.9498, 23.0978, 26.1794, 26.1794, 24.6386, 23.0978, 24.2534, 23.8682, 26.1794, 23.0978, 26.1794, 26.9498, 24.2534, 24.2534, 26.9498, 24.2534, 25.409, 26.1794, 24.6386, 24.6386, 24.6386, 26.1794, 22.7126, 26.1794, 23.0978, 23.0978, 26.1794, 25.0238, 26.1794, 24.6386, 26.1794, 24.6386, 22.7126, 24.2534, 25.409, 26.1794, 25.409, 23.483, 24.2534, 26.1794, 24.2534, 26.1794, 25.409, 23.0978, 26.5646, 23.0978, 24.6386, 25.409, 24.2534, 26.1794, 25.7942, 25.7942, 26.1794, 24.6386, 26.1794, 23.0978, 23.0978, 25.409, 23.0978, 26.5646, 24.6386, 23.0978, 23.0978, 24.2534, 26.1794, 23.0978, 23.8682, 25.7942, 26.1794, 26.5646, 23.0978, 26.1794, 23.483, 26.1794, 26.1794, 26.1794, 25.409, 24.6386, 25.409, 26.1794, 26.1794, 24.6386, 24.6386, 26.1794, 26.1794, 25.7942, 26.1794, 23.0978, 23.0978, 26.1794	ATGCCCTGGCGGGAGGTGCTGGAACGGCTGCTGGCCTACGAGGTCGACCTCATCGTCATCTCGGGCGGCGAACCGCTCAACCAGCAGCGCCGCCTGCTGCCCCTGGTGCGCGCGCTCCGCGACCACGGACGTGACGTGGAGATCGAGACCAACGGCACGGTCGCGCCGGACGCCGGCCTGGTGACCGGCGGCGTGCGGTTCAACGTCTCCCCCAAGCTGTCCCACTCCGGCGACCCCGAGAGCCGGCGGATCGTGCCCGAGGCGCTGCGGGCGCTGGCCGCGGTCCCCGGCACCGCCTTCAAATTCGTCTGCCGCGACGAGGAGGACCTGGAAGAGGTCGCCTCCGTCGTGGACCGCTGCGGCACCCGGCCGGTCTGGATCATGCCCGAAGGCCAGACGTCCGAAGCCACCCACCGACATCTCGCACGGCTCGGCGATCACGTCGTAGCACGCGGATGGAACCTCACCACACGCCTTCACGTGGCCGTGTGGGGCGACAGGAGAGCCATATGA	MPWREVLERLLAYEVDLIVISGGEPLNQQRRLLPLVRALRDHGRDVEIETNGTVAPDAGLVTGGVRFNVSPKLSHSGDPESRRIVPEALRALAAVPGTAFKFVCRDEEDLEEVASVVDRCGTRPVWIMPEGQTSEATHRHLARLGDHVVARGWNLTTRLHVAVWGDRRAI	MYKKALIAATSILFLSSCSSNTVKQHQIHSISANKNSEEIKSLFDQAQTTGVLVIKRGQTEEIYGNDLKRASTDYVPASTFKMLNALIGLEHHKVTTTEVFKWDGQKRLFPDWEKDMTLGDAMKASAIPVYQELARRIGLDLMSKEVKRIGFGNADIGSKVDNFWLVGPLKISPEQETQFAYKLANKTLPFSKNVQEQVQSMVFIEEKNGSKIYAKSGWGWDVEPQVGWLTGWVVQPQGEIVAFSLNLEMKKGTPSSIRKEIAYKGLEQLGVL	BGC0000879.1|Toyocamycin/sangivamycin_5#4967#5479#1#ID=1_5;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.704	gnl|BL_ORD_ID|201|hsp_num:0	397
BGC0000879.1|Toyocamycin/sangivamycin_10	ID=1_10;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.733	9724	10254	+	Loose	n/a	0.449823	oleB	39.47	ARO:3003905, ARO:3003036, ARO:3002921, ARO:3002870, ARO:3002914, ARO:3004100	ANT(4')-Ib, tet34, LpeB, vanRB, oleB, vanJ	protein homolog model	n/a	efflux pump complex or subunit conferring antibiotic resistance	antibiotic inactivation enzyme; antibiotic resistance gene cluster, cassette, or operon; determinant of aminoglycoside resistance; determinant of resistance to glycopeptide antibiotics; determinant of tetracycline resistance; efflux pump complex or subunit conferring antibiotic resistance; protein(s) conferring antibiotic resistance via molecular bypass	1700	26.9498	24.2534, 26.9498, 22.7126, 28.4906, 23.0978, 24.2534	ATGACCGCCGGACCGTCCCTGTGGAAGCGGCAGCGACTGCTCACCATGAGCTGGCAGACGCTCGGTACGCTGCTGACCGGCCTCGCCGAGGAGATCCGCGCCGCGGGCCCCCTCCCGGACACCGTCGTCGGTATCACCCGCGGCGGGCTCACCCCAGCCGTCGCCCTGGCGCACCGGCTGGACGTACCGGAGTTCCGGATCATGGGCATCCCGCGCAACTCCTCCAACAGCCGGTACAGCGAGCGCGGCGCGGCGGCACTGGAGTACGTCGTCCCGGACACCCCGCTGACGGGCAAGCGCGTCCTGGTCGTCGACGACATCATGGGCGACGGCGGCACGATGGAGACCGCGGTCGGCACCCTGCGTGCCCTGGACGCCGCGGAGATCCGCACCGCGGTCCTGGTGCGCAACCAGAACTGCGCCGGCCGGCCGGACCACCAGGGCGTCGAGGTCGACGACTGGACGGTCTTCCCGTGGGAGGCTCCGCCGGGCCCGGCGGAGCCGACCGTGCCGCTGGAGGCCGTGCGGTGA	MTAGPSLWKRQRLLTMSWQTLGTLLTGLAEEIRAAGPLPDTVVGITRGGLTPAVALAHRLDVPEFRIMGIPRNSSNSRYSERGAAALEYVVPDTPLTGKRVLVVDDIMGDGGTMETAVGTLRALDAAEIRTAVLVRNQNCAGRPDHQGVEVDDWTVFPWEAPPGPAEPTVPLEAVR	MQNAHRSDTGAAALTGTPEKLLPTQPETGSFQVVLDDVVRAPGGRPLLDGVNQSVALGERVGIIGENGSGKSTLLRMLAGVDRPDGGQVLVRAPGGCGYLPQTPDLPPEDTVQDAIDHALAELRSLERGLREAEQALAGAEPEELEGLLGAYGDLLEAFEARDGYAADARVDAAMHGLGLAGITGDRRLGSLSGGEQARLNLACLLAASPQLMLLDEPTNHLDVGALEWLEERLRAHRGSVLVVSHDRVFLERVATALWEVDGERRTVNRHGGGYAGYLQAKAAARRRWEQAYQDWLEDLARQRELARSAADHLATGPRRNTERSNQRHQRNVEKQISARVRNAKERVRRLEENPVPRPPQPMRFRARVEGGGTVGRGGALAELYKVTVGTRLDVPSFTVDPGERILITGHNGAGKSTLLRVLAGDLAPDQGECERPERIGWLPQETEITDRQQSLLAAFAAGLPGIAEEHRGALLGFGLFRPSALGTAVGDLSTGQLRRLALARLLRDPADLLLLDEPTNHLSPALVEDLEEALAHYRGALVVVSHDRMFAQRFTGRRMHMEGGRFVE	BGC0000879.1|Toyocamycin/sangivamycin_10#9725#10255#1#ID=1_10;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.733	gnl|BL_ORD_ID|324|hsp_num:0	1388
BGC0000879.1|Toyocamycin/sangivamycin_15	ID=1_15;partial=00;start_type=TTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.690	12268	12984	-	Loose	n/a	7.22411	aadA9	24.44	ARO:3002609, ARO:3002908, ARO:3002844	aadA9, vatE, vanF	protein homolog model	n/a	antibiotic inactivation enzyme; determinant of aminoglycoside resistance	antibiotic inactivation enzyme; antibiotic resistance gene cluster, cassette, or operon; determinant of aminoglycoside resistance; determinant of resistance to glycopeptide antibiotics; determinant of streptogramin resistance; protein(s) conferring antibiotic resistance via molecular bypass	400	23.8682	23.8682, 23.8682, 23.483	TTGCCCGAATCGCCGGTCGAGGCCGACCCGTTCAGCGCCGTCGTCGTGCTGTCCGGCGGCATGGACTCCACGACGCTGCTCGCCCATTACGCCATGCTGCGCTACCGGCTCACCGCGGTGACGGTCGACTACGGTCAGCGCCACCGCCGGGAGATCGACGCGGCCCGGACGATCGCCGGGCACTACGGCGCGGAACACCATGTGGTGGACCTGAGCGGTATCGGGGTCCTGCTGGGCGGCTCCGCCCTGACCGACAGTGAGGTCGACGTCCCCTCAGGGCACTACGCCGAGGAGTCGATGCGGGCCACCGTCGTCCCCAACCGCAATGCCATCCTGGCCAATGTGGCGGTGGGCGCCGCGGTCGCGCGGCAGGCCGGCATCGTGGCTCTCGGAATGCACGCCGGTGACCATTTCGTCTATCCCGACTGCCGGCCGGCGTTCGTCGAGGCGCTGGACGGACTCGTCCGGGTCGCGAACGAGGGATTCGCCACGCCGCGGGTGGAAGCGCCATTCATCCACTGGAGCAAGACGGACATCGCGCGGTACGGGAGCCGGCTGGAAGCCCCGCTGGACAAGAGCTGGTCGTGCTACCGCGGCGGAGAACTCCACTGCGGTACCTGCGGTACGTGTTACGAACGCCGTGAGGCATTCCGTGACGCGGACGTGCCGGACCCGACGGAATACCTCGACGCCGCCACCGAATTCGCAGCGCCGTGA	LPESPVEADPFSAVVVLSGGMDSTTLLAHYAMLRYRLTAVTVDYGQRHRREIDAARTIAGHYGAEHHVVDLSGIGVLLGGSALTDSEVDVPSGHYAEESMRATVVPNRNAILANVAVGAAVARQAGIVALGMHAGDHFVYPDCRPAFVEALDGLVRVANEGFATPRVEAPFIHWSKTDIARYGSRLEAPLDKSWSCYRGGELHCGTCGTCYERREAFRDADVPDPTEYLDAATEFAAP	MLWSSNDVTQQGSRPKTKLDMMSNSIHTGISRQLSQARDVIKRHLASTLKAIHLYGSAIDGGLKPYSDIDLLVTVDARLDEATRRSLMLDFLNISAPPCESSILRPLEVTVVACNEVVPWRYPARRELQFGEWLREDILEGVFEPAALDADLAILITKARQHSIALVGPVAQKVFMPVPEHDFLQVLSDTLKLWNTHEDWENEERNIVLTLARIWYSTETGGIVPKDVAAEWVLERLPAEHKPILVEARQAYLGLCKDSLALRADETSAFIGYAKSAVADLLEKRKSQTSHICDGAKNV	BGC0000879.1|Toyocamycin/sangivamycin_15#12269#12985#-1#ID=1_15;partial=00;start_type=TTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.690	gnl|BL_ORD_ID|1952|hsp_num:0	323
BGC0000879.1|Toyocamycin/sangivamycin_6	ID=1_6;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.711	5475	6077	+	Loose	n/a	1.92751	acrD	35.0	ARO:3000491	acrD	protein homolog model	n/a	efflux pump complex or subunit conferring antibiotic resistance	efflux pump complex or subunit conferring antibiotic resistance	2100	25.409	25.409	ATGACGACGAGCGCCGAAACCCGCACGCTGGAGCTGCCGCGCGAGCACGCGGAGCCGGGCACCGACCCCCTGGAGACGCTGGCACGGCAGCTCCTCACCGAGATCGGTGAGGACCCGGACCGCTCCGGCCTGCGGGACACGCCGGCCCGCTTCGCGCGGTGGTGGAGGGAGTTCACCCAGTACGACCCCGGCCAGGTCGAGACCGTCTTCCCGCTGCACACCGTCGGGCAGCTGGTCACGGTCTCCGACATCCATGTGTGGTCGCTGTGCGAGCACCACCTGCTCCCGTTCTCGTGCACGCTCACGATCGCCTACCGGCCGGCGTCCCACGTGCTCGGGCTCTCGAAGTTCGCCCGTATCGCCCACCGCCACGCGCACCGGCTGCAGATCCAGGAGCGCCTCGTGCACGACATCGCTTCCGAGATCACGGCGGTGACCGGGTCGCCCGACGTGGCCGTGATCGGCAAGGGCGAGCACCTGTGCATGAGCATGCGGGGCATCCGCACGCCGGCGGTGATGACCTCGTCGGCGTTCACCGGGATCTTCGAGGACTTCGGGCCGGCGCGCGACGAGGTCGTGAGCGCGGCCGGCGGACCCCGCTGA	MTTSAETRTLELPREHAEPGTDPLETLARQLLTEIGEDPDRSGLRDTPARFARWWREFTQYDPGQVETVFPLHTVGQLVTVSDIHVWSLCEHHLLPFSCTLTIAYRPASHVLGLSKFARIAHRHAHRLQIQERLVHDIASEITAVTGSPDVAVIGKGEHLCMSMRGIRTPAVMTSSAFTGIFEDFGPARDEVVSAAGGPR	MANFFIDRPIFAWVLAILLCLTGTLAIFSLPVEQYPDLAPPNVRVTANYPGASAQTLENTVTQVIEQNMTGLDNLMYMSSQSSGTGQASVTLSFKAGTDPDEAVQQVQNQLQSAMRKLPQAVQNQGVTVRKTGDTNILTIAFVSTDGSMDKQDIADYVASNIQDPLSRVNGVGDIDAYGSQYSMRIWLDPAKLNSFQMTAKDVTDAIESQNAQIAVGQLGGTPSVDKQALNATINAQSLLQTPEQFRDITLRVNQDGSEVRLGDVATVEMGAEKYDYLSRFNGKPASGLGVKLASGANEMATAELVLNRLDELAQYFPHGLEYKVAYETTSFVKASIEDVVKTLLEAIALVFLVMYLFLQNFRATLIPTIAVPVVLMGTFSVLYAFGYSVNTLTMFAMVLAIGLLVDDAIVVVENVERIMSEEGLTPREATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGTTGAIYRQFSITIVAAMVLSVLVAMILTPALCATLLKPLKKGEHHGQKGFFAWFNQMFNRNAERYEKGVAKILHRSLRWIVIYVLLLGGMVFLFLRLPTSFLPLEDRGMFTTSVQLPSGSTQQQTLKVVEQIEKYYFTHEKDNIMSVFATVGSGPGGNGQNVARMFIRLKDWSERDSKTGTSFAIIERATKAFNQIKEARVIASSPPAISGLGSSAGFDMELQDHAGAGHDALMAARNQLLALAAENPELTRVRHNGLDDSPQLQIDIDQRKAQALGVAIDDINDTLQTAWGSSYVNDFMDRGRVKKVYVQAAAPYRMLPDDINLWYVRNKDGGMVPFSAFATSRWETGSPRLERYNGYSAVEIVGEAAPGVSTGTAMDIMESLVKQLPNGFGLEWTAMSYQERLSGAQAPALYAISLLVVFLCLAALYESWSVPFSVMLVVPLGVIGALLATWMRGLENDVYFQVGLLTVIGLSAKNAILIVEFANEMNQKGHDLFEATLHACRQRLRPILMTSLAFIFGVLPMATSTGAGSGGQHAVGTGVMGGMISATILAIYFVPLFFVLVRRRFPLKPRPE	BGC0000879.1|Toyocamycin/sangivamycin_6#5476#6078#1#ID=1_6;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.711	gnl|BL_ORD_ID|2047|hsp_num:0	1427
BGC0000879.1|Toyocamycin/sangivamycin_3	ID=1_3;partial=00;start_type=TTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.661	4342	4707	+	Loose	n/a	5.0416	MexK	37.93	ARO:3003693, ARO:3001306, ARO:3004100, ARO:3000502	LpeB, AcrF, MexK, ErmW	protein homolog model	n/a	efflux pump complex or subunit conferring antibiotic resistance	antibiotic target modifying enzyme; determinant of lincosamide resistance; determinant of macrolide resistance; determinant of streptogramin resistance; efflux pump complex or subunit conferring antibiotic resistance	2050	23.0978	23.0978, 22.3274, 24.6386, 24.2534	TTGGGATTCCGTATCAGCAAAGAGTTCCACTTCTCCGCGAGCCACCGTCTGGACCACCTCGACGAAGGCCATCCCTGTTCCCGTATGCACGGGCACAACTACGTCGTCGAACTCGAACTGTCCGCCGGCGACGACGCCCTGACCAAGGCCGGCTTCGTCCGTGACTACGGGGAGCTCGCGGCCTTCAAGCAGTGGCTCGACGCCGAACTCGACCACCGGCACCTCAACGACGTGGTCGACGGCCTGAACCCGTCCGCCGAGAACCTGGCGCGGTGGATCCACGAGCGGTGGCGCACCGGCTTCCCGGAGCTGACCGCGGTCCGGGTCTCCGAGACCGACAAGACGTGGGCGGAGTACCGGGCATGA	LGFRISKEFHFSASHRLDHLDEGHPCSRMHGHNYVVELELSAGDDALTKAGFVRDYGELAAFKQWLDAELDHRHLNDVVDGLNPSAENLARWIHERWRTGFPELTAVRVSETDKTWAEYRA	MSFNLSAWALQNRQIVLYLMILLGAVGALSYSKLGQSEDPPFTFKAMVVQTNWPGASAEEVARQVTERIEKKLMETGDYDRIVSFSRPGVSQVTFMAREDIHSSEIPELWYQIRKKISDIRATLPQSIQGPFFNDEFGTTYGNIYALTGKGFDYAVMKDYADRLQLQLQRIRNVGKVELIGLQDEKIWIDLSNTKLATLGLPLAAVQKALEEQNAVASSGFFETASDRVQLRVSGRFDSVEEIRDFPIRVGDRTFRIGDVAEVRRGFNDPPAPRMRFMGEDAIGLAVAMKPGGDILVLGKALETEFARLQQSLPAGLELRKVSDQPAAVRTGVGEFIRVLAEALVIVLLVSFFSLGLRTGLVVALSIPLVLAMTFAAMHYFGIGLHKISLGALVLALGLLVDDAIIAVEMMAVKMEQGYDRLKAASFAWTSTAFPMLTGTLITAAGFLPIATAQSGTGEYTRSLFQVVTIALVVSWFAAVVFVPYLGAKLLPDLARLHAQKHGGSADGYDPYATAFYQRFRRLVEWCVRYRKTVIVLTLAAFVGALLLFRLVPQQFFPPSARLELLLDIKLAEGASLRSTGEEVQRLEKMLQGHDGIDNYVAYVGTGSPRFYLPLDQQLPAASFAQVVVLAKDLESREALRKWLIERMNEDFPHLRSRISRLENGPPVGYPVQFRVSGEDIPQVRELARKVADKMRENPHVVNVHLDWEEPSKVVYLSIDQERARALGVSTASLSQFLQSALTGSHVSFFREDNELIEILLRGTEQERRDLSLLPSLAVPTENGRSVALSQIATLEYGFEEGIIWHRNRLPTVTVRADIYDDSLPATLVAQIAPTLEPIRAELPDGYLLEVGGTVEDAAKGQSSVNAGVPLFIVVVLSLLMVQLRSFSRMAMVFLTAPLGLIGVTLFLLLFRQPFGFVAMLGTIALAGMIMRNSVILVDQIEQDISHGLDRWHAIIEATVRRFRPIVLTALAAVLAMIPLSRSVFFGPMAVAIMGGLIVATVLTLLFLPALYAAWFRVKKDEARA	BGC0000879.1|Toyocamycin/sangivamycin_3#4343#4708#1#ID=1_3;partial=00;start_type=TTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.661	gnl|BL_ORD_ID|374|hsp_num:0	2206
BGC0000879.1|Toyocamycin/sangivamycin_2	ID=1_2;partial=00;start_type=ATG;rbs_motif=AGGAG/GGAGG;rbs_spacer=11-12bp;gc_cont=0.746	1167	4052	+	Loose	n/a	0.244994	evgA	32.61	ARO:3000832, ARO:3000826	evgA, sdiA	protein homolog model	n/a	efflux pump complex or subunit conferring antibiotic resistance; protein(s) and two-component regulatory system modulating antibiotic efflux	efflux pump complex or subunit conferring antibiotic resistance; protein(s) and two-component regulatory system modulating antibiotic efflux	470	30.4166	30.4166, 36.5798	ATGAGTGTGGCAACGCCGACAGCGGAAGACACGTACCGCGCGAAGGACTCCGCGGTGCTCGCCCCTCGTCCGGAAATGCGGGTGTTACGCCAGGCACTGGCCGACAGCGGCGCCGGACGGGGCGGTCACTGGGTCGTGTACGGAGAAACCGGCGCGGGAAAGACCTCCGTTCTGCGCGCCCTTCGCGAAGAGGCCCGCGTGCTCGGCCACGCGGCCGTGGAACTGAAGTGCACGCCGATGGAGGGGTGCGTACCGTTCGCCACCGCGCGCAAGCTCGTCGCGCTGTTCGGCGCGTCACTCCCGGCGAGAGGTCCCGCCGCGGAAGCCCTGCGCCGGGCCGGCAGAGCGCTTTCGGGCCGTAACGGCTCGGCCGCGGGCCGGGGCTCGGGGCTGGGCGTGGTGCTCACCGGGCTCCAGGAGGCGGCCCAGGCCCTCACCGCGGCGGCCCCGCTGCTCATCACGGTCGACGACATCGGCTCGGCCGACGCCGCCTCGCTGGACTGCTTCTCCTACCTGCTGAACCAGTGCGAGGGAGTGCACCGCCTCCTGATCGTCGCGACGCTGGCCGACGGGGAACCGGTGCAGGCGCCGGCCGCGCTGGAGGGGCTGCGGCTCGGCGCCCGGGGACGTATCGACCTCGGCGGTCTCGACCTGCCGGGCACGGCCGAACTGGTGGCAGCCGTGACCGGCCGGCCGTGTGACGAGGGCCTCGCGGCGGCCTGCCGCACGGCGACGGCGGGCAACCCGCTGTTCCTGCGGGCCCTCGCGCGGTGCCTGCCGGCCCGGCGGCCCGTCCCCGCGCACGAGATCGCCGGGCTGGGGCCGCGAGCCGTCGCCGACCACGTACTGGCCCGGCTCGCGCGGATCTCGGAGCCGGCGTCGGCCATGGCCCGTACGGTCGCCGTACTCGGTGACGACACCGATCCGGCGATGGTCGCGGAGCTGGCGAACCTGGACTGCTCGACGGGCCTGGAGGCGGCGGACGTCCTGGTGCGCACGCGGCTGTTCCACGACGGGGGACAGATGTCGTTCCGCCATCCCGTCGTGGCGGCGGCGCTCCGCGAACAGACCTCCATCGTCGTCAAGAACACCCTGCACATGCAGGCCGCCGAGCATCTGCTCAGCCGTGACGCCCCGGCCGAGCAGGTGGCCGGGCACCTGATGGCGACCACCCTTCCCCTCACGTCCTCCTGGATGGTGGACGCGCTGCGGTCGGCGGCGCGGTCCGCCCTGGTACGGGAGGAAACGGGCACGGCAGTGGGGTACCTGCAACGGGCCGTGCAGGACGCGCGGGGCGTGGACTGGCGGCGGGCGGTCGCGCAGCTCGCGGACGCACAGCTGCTCACCGACCCCTCCGCCGCCATCGGCCGGCTCGCGGAGCTGGCCCGCCAGGGCGTGACCGCCGAAGAGCACCCGCAGCTCCTGGCCCGGCTCGCGGACGCGTCGTTCTTCTTCGCCACCCGCCCCCGGATACGGCACCAGCTGGACGAGGCGGTCGAGGCGGTCGCCGTCTCGCAGCCGCACTACACCGCCGACACACAGCTGTACCGGGCCCTGCACGCGCTGTCCGAGCTGCCCACCAAGGAAGCGTGCGAACTCGGGGACCGCTACCTCGCGTCCGAGCCCCGGGAAGGTGTGCTGCGCAGCGCGGCCGGGGCCCTGAGCGCCGTGAGCGCCTATGCGGCGGGCCGGGGCAGAAAGGCCGCGGTGGACCGGGTGAAGGAGGCGCTACGCGACCCCGACCTGTACGAACTCCCCAACACCGCGCCCCTGTGCGCCGGCACCGCGCTGCTGGCGCACGAGGGCGACCTCGACCTGGCCTCGGAGTACGCCCGGCACGGCATCGCCGTCGCGCGGCGGGAAGGGCGGCAGCTCCAGGTCGCCGCGCTCCTGCCGACCCTGGCGAAGATCGCCCAGGTACGCGGGGACCTGCGCGAGGCGGAGAACCTGCTGCGCACCTGCCTGAAGACCTTCGCGCGGTACGGGGTGTGGCGGGCCAACCCGGCCGCCCTCTGGGCCGGTTCCGTACTGGTCGGCGTCCTGGTCGACCTGGGCGAGCCGGCCGCCGCCCGCACGGTGCTCAGCGAGAGCGGCTGCCACGGCGACCTGCCGGCGATGTGGTCGACGCAGGCGATGCTGGAGCAGCGGGCCCGGGTGCGCATGGCGGCCGGAGAACTCACCGACGCGCTGGAGGACCTGCGCGAGTGCGGCCGGCGCTCGGCGGCGCTGGGCCTGAACAGCGTCGAGTTCGGGGGCTGGCGCCGGCTGGCCGCCGAGGTGCTGCACCAGTTGGGGCGGCCCGACGAGGCGAGGCGGCTGGCGGAGGAGGAGCTGGCGGCCGTACGGGGCCAGGCCACCGACCGTACCCAGGGAGCCGCCCTGCGCACGGCAGCACGGGTCATCGGCGGCGACGCGGGCCTGGGGCCGGCGCGGGAGGCGGTGCGGATCCTGGCGGGCACCCCCGACGTGCTGGAGCTGGCCCGCGCCCAGCTGACGCTGGGCACCCTGCTCGGGGGCACCGGCGACCGGACCGCCGCCCAGGGAACCCTGGCGCAGGCGCACGCGCTCGCGAGCCGCTGCGGTGCGGCGCCGGTCGAGGAACAGGCCCGCGAGCAGCTGCACGCCCTGGGGCGGCAGCACGGCGGCCGGGCCGTGACCGGGCTGCTGTCCCTGACCAGACGGGAGCGGCAGGTACTGGCCGATGCCGTACGCGGCCGCAGCAACGGCGCGATCGCCGACGCCCTCTTCATCACCCGGCGCACCGTGGAGATTCATCTGACCAGTGCCTACCGCAAACTCGGCATCCAAGGGCGCAAGGAGTTCGCGCAGCTCTACAACCGGCAGGAATTGTGGGCCCTGTTGACGGAGGAAACGGCCGGCAGGTGA	MSVATPTAEDTYRAKDSAVLAPRPEMRVLRQALADSGAGRGGHWVVYGETGAGKTSVLRALREEARVLGHAAVELKCTPMEGCVPFATARKLVALFGASLPARGPAAEALRRAGRALSGRNGSAAGRGSGLGVVLTGLQEAAQALTAAAPLLITVDDIGSADAASLDCFSYLLNQCEGVHRLLIVATLADGEPVQAPAALEGLRLGARGRIDLGGLDLPGTAELVAAVTGRPCDEGLAAACRTATAGNPLFLRALARCLPARRPVPAHEIAGLGPRAVADHVLARLARISEPASAMARTVAVLGDDTDPAMVAELANLDCSTGLEAADVLVRTRLFHDGGQMSFRHPVVAAALREQTSIVVKNTLHMQAAEHLLSRDAPAEQVAGHLMATTLPLTSSWMVDALRSAARSALVREETGTAVGYLQRAVQDARGVDWRRAVAQLADAQLLTDPSAAIGRLAELARQGVTAEEHPQLLARLADASFFFATRPRIRHQLDEAVEAVAVSQPHYTADTQLYRALHALSELPTKEACELGDRYLASEPREGVLRSAAGALSAVSAYAAGRGRKAAVDRVKEALRDPDLYELPNTAPLCAGTALLAHEGDLDLASEYARHGIAVARREGRQLQVAALLPTLAKIAQVRGDLREAENLLRTCLKTFARYGVWRANPAALWAGSVLVGVLVDLGEPAAARTVLSESGCHGDLPAMWSTQAMLEQRARVRMAAGELTDALEDLRECGRRSAALGLNSVEFGGWRRLAAEVLHQLGRPDEARRLAEEELAAVRGQATDRTQGAALRTAARVIGGDAGLGPAREAVRILAGTPDVLELARAQLTLGTLLGGTGDRTAAQGTLAQAHALASRCGAAPVEEQAREQLHALGRQHGGRAVTGLLSLTRRERQVLADAVRGRSNGAIADALFITRRTVEIHLTSAYRKLGIQGRKEFAQLYNRQELWALLTEETAGR	MNAIIIDDHPLAIAAIRNLLIKNDIEILAELTEGGSAVQRVETLKPDIVIIDVDIPGVNGIQVLETLRKRQYSGIIIIVSAKNDHFYGKHCADAGANGFVSKKEGMNNIIAAIEAAKNGYCYFPFSLNRFVGSLTSDQQKLDSLSKQEISVMRYILDGKDNNDIAEKMFISNKTVSTYKSRLMEKLECKSLMDLYTFAQRNKIG	BGC0000879.1|Toyocamycin/sangivamycin_2#1168#4053#1#ID=1_2;partial=00;start_type=ATG;rbs_motif=AGGAG/GGAGG;rbs_spacer=11-12bp;gc_cont=0.746	gnl|BL_ORD_ID|621|hsp_num:0	1015
BGC0000879.1|Toyocamycin/sangivamycin_11	ID=1_11;partial=00;start_type=GTG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.752	10251	10976	+	Loose	n/a	2.09867	APH(7'')-Ia	38.46	ARO:3002661, ARO:3000858, ARO:3003679	APH(7'')-Ia, TriA, armA	protein homolog model	n/a	antibiotic inactivation enzyme; determinant of aminoglycoside resistance	antibiotic inactivation enzyme; antibiotic target modifying enzyme; determinant of aminoglycoside resistance; efflux pump complex or subunit conferring antibiotic resistance	730	25.409	25.409, 23.483, 25.409	GTGACGCTCCCCAGCGCGTCCGGGGCGCGGGTCTCCCGTGCCCCGGCGCGGCCCTCCCCCGCCACGGTCGTCTTCGACCGGGACGGCACCCTGCTGGACTTCTACGACATGTTCCACCGCTTCATCGTCGACCTGCACGACGCCCACGGGGTGGCGCCGCCCTCCCGGGAGGTGATCCTCGCGTACGAGTACTGGCAGACGATCACCAGCGGCCGGCTGCGCATCGGGGACACGGTCGTCCGCGACCGCGTGGACGAGGTGGTCCACCGCTACATGCCGCACGGCCGCCTCTTCCCCGGCACCGCGGAAGCGGTACGTGACCTGGGCGCGGCCGGCGTACGCGTGGTGCTGGTGAGCAGCTGGGTCGGCACCGCGGCGACCGGGGAACTCCTCGAACGGTACGGACTGCGCGGCGCGTTCGGCGCCGTCCTGACCCGCGACGACCTGGCGGCCGACGCGTCCCTGGCCACCGACGCGGAGTGCAAGACGGTCCTCGCCCGCCGGGCCCTGGCCGAGGTGGGACACCAGCCGGGCGACGCCCTGTACCTGGTCGGGGACACCTCGGCGGACATCGCTTCGGCCCGGATGCTCGGGGCCCGGGCCATCGGCGTGCGCACCGGAAACGGCAGCCGGCTGGCCGCGGTACCGGACGCCGGCCCGGACCGTCTCGTGGCCTGCGCCGCCGAGGCCGCGGCCGTCATCCTGCGGGAGGTGCGCGCGGGGTGA	VTLPSASGARVSRAPARPSPATVVFDRDGTLLDFYDMFHRFIVDLHDAHGVAPPSREVILAYEYWQTITSGRLRIGDTVVRDRVDEVVHRYMPHGRLFPGTAEAVRDLGAAGVRVVLVSSWVGTAATGELLERYGLRGAFGAVLTRDDLAADASLATDAECKTVLARRALAEVGHQPGDALYLVGDTSADIASARMLGARAIGVRTGNGSRLAAVPDAGPDRLVACAAEAAAVILREVRAG	MTQESLLLLDRIDSDDSYASLRNDQEFWEPLARRALEELGLPVPPVLRVPGESTNPVLVGEPDPVIKLFGEHWCGPESLASESEAYAVLADAPVPVPRLLGRGELRPGTGAWPWPYLVMSRMTGTTWRSAMDGTTDRNALLALARELGRVLGRLHRVPLTGNTVLTPHSEVFPELLRERRAATVEDHRGWGYLSPRLLDRLEDWLPDVDTLLAGREPRFVHGDLHGTNIFVDLAATEVTGIVDFTDVYAGDSRYSLVQLHLNAFRGDREILAALLDGAQWKRTEDFARELLAFTFLHDFEVFEETPLDLSGFTDPEELAQFLWGPPDTAPGA	BGC0000879.1|Toyocamycin/sangivamycin_11#10252#10977#1#ID=1_11;partial=00;start_type=GTG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.752	gnl|BL_ORD_ID|1874|hsp_num:0	706
BGC0000879.1|Toyocamycin/sangivamycin_16	ID=1_16;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.723	13221	13748	+	Loose	n/a	2.7755	APH(6)-Id	33.33	ARO:3002660, ARO:3000027, ARO:3003942	emrA, APH(6)-Id, abcA	protein homolog model	n/a	antibiotic inactivation enzyme; determinant of aminoglycoside resistance	antibiotic inactivation enzyme; determinant of aminoglycoside resistance; efflux pump complex or subunit conferring antibiotic resistance; protein(s) and two-component regulatory system modulating antibiotic efflux	3000	24.2534	24.2534, 23.0978, 24.2534	ATGACGACCGAGACCGGCCCCGTACAGCTGCTGACGATCGCGTTCGGCCCGGACGCGAAGTTCGAGGGGCGGATCATCGAGGAACTCGACGGCCTCACGGCCGCGGGCCAGATCCTCGTACTGGACCTGCTGGTCGTACAGAAGCAGCCCGGCGGTGACCTCGTCTCCGTCGGCTACCAGGCGGAAGGCATGGGCGACACGGTCAGCGCCCTGCTCGGACTGGGTCCGGGCGGCCTGCGGGGAGCGGAGGCGGCGTTCCCGTCCCTGGCACCGGGCCGCGCCTTCGGCCTCGGCGCGGACGACGTCCGGCAGCTCGCCGACTCCCTGGACCCGGGCACCACCGCGGCTTTCCTGCTGCTCGAACACCGCTGGGCGCGGAAGCTGCGGCACCTGGTCCGTGAGCAGGGAGGCGTGCCCGTGGCCGAGGGGTTCCTCACCGAAGAAGCGGTCGCCCCCATCGCCGCGGAGCTGCTCGCCGCCGCCACACGGCTGGACGAGGGGCCGACGGGAGAAAGGGGAGGGTCATGA	MTTETGPVQLLTIAFGPDAKFEGRIIEELDGLTAAGQILVLDLLVVQKQPGGDLVSVGYQAEGMGDTVSALLGLGPGGLRGAEAAFPSLAPGRAFGLGADDVRQLADSLDPGTTAAFLLLEHRWARKLRHLVREQGGVPVAEGFLTEEAVAPIAAELLAAATRLDEGPTGERGGS	MFMPPVFPAHWHVSQPVLIADTFSSLVWKVSLPDGTPAIVKGLKPIEDIADELRGADYLVWRNGRGAVRLLGRENNLMLLEYAGERMLSHIVAEHGDYQATEIAAELMAKLYAASEEPLPSALLPIRDRFAALFQRARDDQNAGCQTDYVHAAIIADQMMSNASELRGLHGDLHHENIMFSSRGWLVIDPVGLVGEVGFGAANMFYDPADRDDLCLDPRRIAQMADAFSRALDVDPRRLLDQAYAYGCLSAAWNADGEQEQRDLAIAAAIKQVRQTSY	BGC0000879.1|Toyocamycin/sangivamycin_16#13222#13749#1#ID=1_16;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.723	gnl|BL_ORD_ID|947|hsp_num:0	1031
BGC0000879.1|Toyocamycin/sangivamycin_14	ID=1_14;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.659	11976	12251	-	Loose	n/a	2.73375	mtrD	40.62	ARO:3000811, ARO:3004032	mtrD, tetA(46)	protein homolog model	n/a	efflux pump complex or subunit conferring antibiotic resistance; protein(s) and two-component regulatory system modulating antibiotic efflux	efflux pump complex or subunit conferring antibiotic resistance; protein(s) and two-component regulatory system modulating antibiotic efflux	1100	23.0978	23.0978, 22.3274	ATGGCACGGCTGAACGACATCGGCGGCACTTTCGGTTACGGCAGCATTCCGATGGACGGTGCGGAACCGCCGCACCCGTGGCGGCACGACTGGGAAGCACGGGTGTTCGCCGTGCTGATCGGCCTGGCGATGGCCGGTGTCTGGACCGCCTCGGAACTCCGCGACGCCGAGGAGCGCGTCCCGCCCAACGATTACCTCGCGGCCAGTTATTACGAGCGGGTGCTCATGGGCATGGAACTCCTCCTGGACGAGAAGGGGATTCCCTCCCGTGGGTGA	MARLNDIGGTFGYGSIPMDGAEPPHPWRHDWEARVFAVLIGLAMAGVWTASELRDAEERVPPNDYLAASYYERVLMGMELLLDEKGIPSRG	MAKFFIDRPIFAWVISIFIIAAGIFGIKSLPVSQYPSVAAPTITLRATYPGASAQVMEDSVLSVIERNMNGVEGLDYMSTSADSSGSGSVSLTFTPDTDENLAQVEVQNKLSEVLSTLPATVQQYGVTVSKARSNFLMIVMLSSDVQSTEEMNDYAQRNIVPELQRIEGVGQVRLFGAQRAMRIWVDPKKLQNYNLSFADVGSALSAQNVQISAGSIGSLPAVRGQTVTATVTAQGQLGTAEEFGNVILRANTDGSNVYLKDVARVGLGMEDYSSSTRLNGVNTTGMAVMLSNSGNAMATAKAVKERMATLEKYFPQGMSWKTPYDTSKFVEISIEKVIHTLIEAMVLVFVVMYLFLQNIRYTLIPTIVVPISLLGGFAFISYMGMSINVLTMFAMVLVIGIVVDDAIVVVENVERIMAGEGLPPKEATKKAMGQISGAVIGITAVLISVFVPLAMFSGATGNIYKQFALTMASSIAFSAFLALTLTPALCATMLKTIPKGHHEEKKGFFGWFNKKFNSWTHGYEGRVAKVLRKTFRMMVVYIGLAVVGVFLFMRLPTSFLPTEDQGFVMVSVQLPAGATQERTNATLAQVTQLAKSIPEIENIITVSGFSFSGSGQNMAMGFAILKDWNERTAPGSDAVAIAGKLTGMMMGTLKDGFGIAVVPPPILELGNGSGLSINLQDRNNTGHTALLAKRNELIQKMRASGLFDPSTVRAGGLEDSPQLKIDINRAAAAAQGISFADIRTALASALSSSYVSDFPNQGRLQRVMVQADEDARMQPADILNLTVPNKSGVAVPLSTIATVSWENGTEQSVRFNGYPSMKLSASPATGVSTGQAMAAVQKMVDELGGGYSLEWGGQSREEAKGGSQTLILYGLAVAAVFLVLAALYESWSIPLAVILVIPLGLIGAAAGVTGRNLFEGLLGSVPSFANDIYFQVGFVTVMGLSAKNAILIIEFAKDLQAQGKSAVEAALEAARLRFRPIIMTSFAFILGVVPLYIAGGASSASQRAIGTTVFWGMLIGTLLSVFLVPLFYVVVRKFFKETAHEHEMAVKHAAEAGITGSDDSQH	BGC0000879.1|Toyocamycin/sangivamycin_14#11977#12252#-1#ID=1_14;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.659	gnl|BL_ORD_ID|1042|hsp_num:0	1938
BGC0000879.1|Toyocamycin/sangivamycin_4	ID=1_4;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.737	4704	4802	+	Loose	n/a	4.95284	AAC(6')-29b	56.25	ARO:3002584, ARO:3000830, ARO:3001306	AAC(6')-29b, cpxA, ErmW	protein homolog model	n/a	antibiotic inactivation enzyme; determinant of aminoglycoside resistance	antibiotic inactivation enzyme; antibiotic target modifying enzyme; determinant of aminoglycoside resistance; determinant of lincosamide resistance; determinant of macrolide resistance; determinant of streptogramin resistance; efflux pump complex or subunit conferring antibiotic resistance; protein(s) and two-component regulatory system modulating antibiotic efflux	400	19.631	19.631, 19.2458, 19.631	ATGACCACGCGGCCCGCGGAGGCCGGGCGGGAGCGGGAAGGGGGTGGCGCCGCGGTGGGACCGAAGCTCGTGGTGAACGAGATCTTCGGCCCCACCTAG	MTTRPAEAGREREGGGAAVGPKLVVNEIFGPT	VSILPVKEQDAADWLALRNLLWLADDHASEIEQYFSGGFEEPAEVLIARDATGAAVGHVELSIRHDLEELQGIKTGYIEGLYVAPSHRSTDLVRRFLRESEKWALEQGCSAFASDRSDRVITHRKFAGSAV	BGC0000879.1|Toyocamycin/sangivamycin_4#4705#4803#1#ID=1_4;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.737	gnl|BL_ORD_ID|252|hsp_num:0	659
BGC0000879.1|Toyocamycin/sangivamycin_7	ID=1_7;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.740	6164	7318	+	Loose	n/a	4.69215	amrB	44.83	ARO:3002983, ARO:3003033	amrB, MexY	protein homolog model	n/a	efflux pump complex or subunit conferring antibiotic resistance	efflux pump complex or subunit conferring antibiotic resistance	2060	25.409	25.409, 26.9498	GTGAAACCGTTGCGTGAAATCCCCACCGGCCTCGGGCTCGACGACGTCCTGCTCGTCCCCCAGCGCACCTCGGTCACCAGCCGTTCGCACACCGACGTCAGTACCGAACTCGTCCCGGGCCTGCGGCTGTCCGTACCGATCCTGTCCGCCAACACCCCGTGGTGCACCGGCGCCCGGATGGCCGCCGCCATGGCGCTGGCGGGCGGGCTCGGGGTCATCCACCGGATGCAGACGGCGGAGGACCAGGCGGCCGAGGTGACCGCGGTGAAGAAGGAACATCCCAAGGAGGAGTCCGCCGCCCCGGGCGCCACGGTCGACGAGCGGGGCCGGCTCCGCGCGGCGGCCGCCGTCGGGGTGACGGACGATTACCTCGACCGGGCGGCCCTCCTCGTCGAGGCCGGGGCCGACGCCCTGGTCGTCGATGTCGCGCACGGCCACGCGGACTACGTCCTCAAGGCCGTGGAGCAGCTGAAGTCCCGCTGGCCCGGCGTGCCCCTCGTGGGCGGCAACGTCGCGACTCCCGCCGGCACCAGGGACCTGATCGACGCCGGGGCGGATGCCGTGAAGGTCGGCATCGGGCCCGGCGGCATCTGCACCACGCGGCTGGTGGCCGGCAGCGGCATGCCGCAGTTCACCGCCGTACTGGAGTGCGCGGAGGAGGCCGCGGGGCGCGGCGTGCCGGTCATCGCGGACGGTGGCATCAAGGAGCCGGGCGACGTCGCGAAGGTGCTGGCGGCCGGTGCCCGGACGGCGATGCTGGGCAGCGCGCTCGCCGGTGCCGAGGAGAGCGCCGCCCTTCTGGTGGAGCACGACGGGCGGCCGGCGAAGGTGAGCACCGGGTTCGTGACGTTCGGCATGCAGCTGACCCTCAAGCGGGCCCGCGGTGAGGCGGTGACCAAGGAGGAACTGGCGCAGTACACGCCCGAAGGCGTGGAGGCGACGTGGCCCTTCAGCGGGCCGGCCGCCGGCACGGTGAACCGTTTCGTCGGCGGGCTGCGCTCCGGGATGAGCTACTCGGGCGCGCACACCCTCGCCGAGTTCCGCGAGCGGGCCTGCTTCGTCCGCGTCACCCCCGCCGGCCTGGCCGAGAACCACCCGCACGCCCTCGGACGCGCCCAGCAGGTCCCGCTCGACTACGCGGCGGAGGCGGTGTGA	VKPLREIPTGLGLDDVLLVPQRTSVTSRSHTDVSTELVPGLRLSVPILSANTPWCTGARMAAAMALAGGLGVIHRMQTAEDQAAEVTAVKKEHPKEESAAPGATVDERGRLRAAAAVGVTDDYLDRAALLVEAGADALVVDVAHGHADYVLKAVEQLKSRWPGVPLVGGNVATPAGTRDLIDAGADAVKVGIGPGGICTTRLVAGSGMPQFTAVLECAEEAAGRGVPVIADGGIKEPGDVAKVLAAGARTAMLGSALAGAEESAALLVEHDGRPAKVSTGFVTFGMQLTLKRARGEAVTKEELAQYTPEGVEATWPFSGPAAGTVNRFVGGLRSGMSYSGAHTLAEFRERACFVRVTPAGLAENHPHALGRAQQVPLDYAAEAV	MARFFIDRPVFAWVISLFIMLGGIFAIRALPVAQYPDIAPPVVSLYATYPGASAQVVEESVTAVIEREMNGVPGLLYTSATSSAGQASLSLTFKQGVSADLAAVDVQNRLKIVEARLPEPVRRDGISIEKAADNAQIIVSLTSEDGRLSGVELGEYASANVLQALRRVEGVGKVQFWGAEYAMRIWPDPVKMAALGLTASDIASAVRAHNARVTIGDVGRSAVPDSAPIAATVLADAPLTTPDAFGAIALRARADGSTLYLRDVARIEFGGNDYNYPSFVNGKTATGMGIKLAPGSNAVATEKRVRATMEELAKFFPPGVKYQIPYETASFVRVSMSKVVTTLVEAGVLVFAVMFLFMQNFRATLIPTLVVPVALLGTFGAMLAAGFSINVLTMFGMVLAIGILVDDAIVVVENVERLMVEEKLPPYEATVKAMKQISGAIVGITVVLTSVFVPMAFFGGAVGNIYRQFAFALAVSIGFSAFLALSLTPALCATLLKPVADDHHEKDGFFGWFNRFVARSTHRYTRRVGRVLERPLRWLVVYGALTAAAALLITKLPAAFLPDEDQGNFMVMVIRPQGTPLAETMQSVRRVEEYVRTHSPSAYTFALGGYNLYGEGPNGGMIFVTMKDWKERKRARDQVQAIIAEINAHFAGTPNTMVFAINMPALPDLGLTGGFDFRLQDRGGLGYGAFVAAREKLLAEGRKDPVLTDLMFAGTQDAPQLKLDIDRAKASALGVSMEEINATLAVMFGSDYIGDFMHGSQVRRVIVQADGRHRLDAADVTKLRVRNAKGEMVPLAAFATLHWTMGPPQLTRYNGFPSFTINGAASAGHSSGEAMAAIERIASTLPAGTGYAWSGQSYEERLSGAQAPMLFALSVLVVFLALAALYESWSIPFAVMLVVPLGVIGAVAGVTLRGMPNDIYFKVGLIATIGLSAKNAILIVEVAKDLVAQRMSLADAALEAARLRLRPIVMTSLAFGVGVLPLAFATGAASGAQIAIGTGVLGGVISATLFAIFLVPLFFVCVGRVFDVVPRRRGGAQAALEAK	BGC0000879.1|Toyocamycin/sangivamycin_7#6165#7319#1#ID=1_7;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.740	gnl|BL_ORD_ID|1672|hsp_num:0	476
BGC0000879.1|Toyocamycin/sangivamycin_9	ID=1_9;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.736	8672	9727	+	Loose	n/a	4.12825	srmB	37.25	ARO:3003060, ARO:3002817, ARO:3002828, ARO:3000491	srmB, carA, acrD, tsnr	protein homolog model	n/a	efflux pump complex or subunit conferring antibiotic resistance	antibiotic target modifying enzyme; determinant of resistance to peptide antibiotics; efflux pump complex or subunit conferring antibiotic resistance	2100	25.409	24.2534, 24.2534, 25.409, 24.2534	ATGCCCTGCACCATCATCGTGGGCGGCCAGTGGGGTGACGAGGCCAAGGGCAAGATGGCCAGTTACCTGGCGCTCAAGGACGGCGTGGACCTCGCGGTGCGCGCCGGCCTCGGCCCGGGAGCCGGGCACACCATCGTGCACGGCGGACGGACGCACAAACTGCGCCAGGTCCCGAGCGCCGTGGTCAACGAGCGGACCCGGCTGCTGCTCGGCGCCGGTGTGCTCGTCAATCCGGAGGTACTGCTGCGGGAGATCGACGAGCTGGGGGTGGCCGACCGTATCGGCGTCGACTTCCGGGCGACCGTCATCGACCCCGGGCACGTCGAGGCCGAGCAGCGCGAACGCAATCTCACCGACACGGTCCGCAGCACCGGCAGCGGACACGGCCCCGCTCTCGCGGCACGCGCACTGCGCAACGCCCGCCGGGCGATGGACGTACCCGAACTGGCCCCCTACCTGGCGGACGTCGCCGTGGAGGTCAACGGCGCGGTGGACGCGGGCGCGCAGGTCCAGGTGGAGGGGACGAACGGGTTCGGCCTGTCGGTCCTGTACGGGACCTACCCGCACACGGTCGGCAAGGACAGCACGGCGAGCACGGCGGCCGCGGACGCCGGGCTGGGTCCGCTGGCCGTGGACGACGTGGTCCTGGTCTTCCGGGCCTACCCCACCCGCGTCGGGGCCGGCGCGTTCCCGACGGAGCTGCCCGAGCAGGAGGCGGAGCGCATCGGGGTCGAGTACGGCACGGTGACCGGACGGCGCCGGCGGATGGGCCGCTTCGACCTGGAGCAGGCCCGGGAGGCCGTACGGATCAACCGGCCCTCGCGCATCGCCGTCAGCTTCCTCGACTACCTGGCGCCGGAGGTCCGGGGGCAGCAGGAGGGCCCGCTGCCGCCCGGCGCGGCGGCCGGCCTCGTCGAAGAGATCGAACGCGAGCTGGGCGTACGGGTCGAGCTCCTCGGCACCGGACCGGGTACGGACGAGGTCATCGACCTGAGGCCCGCCCCCGCCGGCGCCGGCACCACAGCCCCCCTCCTCCGCACAAGGAGCACCGCATGA	MPCTIIVGGQWGDEAKGKMASYLALKDGVDLAVRAGLGPGAGHTIVHGGRTHKLRQVPSAVVNERTRLLLGAGVLVNPEVLLREIDELGVADRIGVDFRATVIDPGHVEAEQRERNLTDTVRSTGSGHGPALAARALRNARRAMDVPELAPYLADVAVEVNGAVDAGAQVQVEGTNGFGLSVLYGTYPHTVGKDSTASTAAADAGLGPLAVDDVVLVFRAYPTRVGAGAFPTELPEQEAERIGVEYGTVTGRRRRMGRFDLEQAREAVRINRPSRIAVSFLDYLAPEVRGQQEGPLPPGAAAGLVEEIERELGVRVELLGTGPGTDEVIDLRPAPAGAGTTAPLLRTRSTA	MSIAQYALHDITKRYHDCVVLDRVGFSIKPGEKVGVIGDNGSGKSTLLKILAGRVEPDNGALTVVAPGGVGYLAQTLELPLDATVQDAVDLALSDLRELEAAMREAEAELGESDENGSERELSAGLQRYAALVEQYQARGGYEADVRVEVALHGLGLPSLDRDRKLGTLSGGERSRLALAATLASSPELLLLDEPTNDLDDRAMEWLEDHLAGHRGTVIAVTHDRVFLDRLTTTILEVDSGSVTRYGNGYEGYLTAKAVERERRLREYEEWRAELDRNRGLITSNVARMDGIPRKMSLSVFGHGAYRRRGRDHGAMVRIRNAKQRVAQLTENPVHAPADPLSFAARIDTAGPEAEEAVAELTDVRVAGRLAVDSLTIRPGERLLVTGPNGAGKSTLLRVLSGELEPDGGSVRVGCRVGHLRQDETPWAPGLTVLRAFAQGREGYLEDHAEKLLSLGLFSPSDLRRRVKDLSYGQRRRIEIARLVSDPMDLLLLDEPTNHLTPVLVEELEQALADYRGAVVVVTHDRRMRSRFTGARLTMGDGRIAEFSAG	BGC0000879.1|Toyocamycin/sangivamycin_9#8673#9728#1#ID=1_9;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.736	gnl|BL_ORD_ID|1999|hsp_num:0	128
BGC0000879.1|Toyocamycin/sangivamycin_13	ID=1_13;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.715	11672	11983	-	Loose	n/a	4.86819	FosA5	53.33	ARO:3004113, ARO:3003209, ARO:3000777, ARO:3004111, ARO:3002804	FosA2, adeF, FosA6, FosA7, FosA5	protein homolog model	n/a	antibiotic inactivation enzyme; determinant of fosfomycin resistance	antibiotic inactivation enzyme; determinant of fosfomycin resistance; efflux pump complex or subunit conferring antibiotic resistance	200	22.3274	21.557, 22.3274, 22.3274, 22.3274, 22.3274	GTGGGTGAACGGCGGTTCTCCGTCGGGGATCCGGTCCGGGTGCGCCCGGCGGATCCGCCCCACCACACCCGGGTGCCCCGGTACGTACGGGGTCACCTCGGGCACGTCGTCACCGTACAACCGCCCTGCCCGCTTCCCGACGACGTGGCCCGGCGCCGGGATCCGTTCCGGGTCCTTCCCGTCTACACCGTGCGCTTCGCAGCGCGCGACCTGTGGGGCAGCGGGACACACCTCGTCCTGATCGACCTGTGGGAGTGCTACCTGGAACCGGCCGCCGAGACGGCCCGGGGCCTTGGAGGAGAAACATCATGA	VGERRFSVGDPVRVRPADPPHHTRVPRYVRGHLGHVVTVQPPCPLPDDVARRRDPFRVLPVYTVRFAARDLWGSGTHLVLIDLWECYLEPAAETARGLGGETS	MLSGLNHLTLAVSQLAPSVAFYQQLLGMMLHARWDSGAYLSCGDLWLCLSLDPQRRVTPPEESDYTHYAFSISEADFASFAARLEAAGVAVWKLNRSEGASHYFLDPDGHKLELHVGSLAQRLAACREQPYKGMVFFAE	BGC0000879.1|Toyocamycin/sangivamycin_13#11673#11984#-1#ID=1_13;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.715	gnl|BL_ORD_ID|2158|hsp_num:0	112
BGC0000879.1|Toyocamycin/sangivamycin_1	ID=1_1;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.715	468	758	+	Loose	n/a	2.57896	TEM-96	42.31	ARO:3000963, ARO:3000944, ARO:3000990, ARO:3001374	TEM-78, TEM-96, TEM-128, TEM-185	protein homolog model	n/a	antibiotic inactivation enzyme; determinant of beta-lactam resistance	antibiotic inactivation enzyme; determinant of beta-lactam resistance	500	23.0978	23.0978, 23.0978, 22.3274, 23.0978	ATGACTGCATTTGACGACGGGGAGCATCACGGACGGTACGGAAGGCGCGAAGCCGATGTCCGTGAAGCCGTGTCGGTGACCGCCTTCACCGCGGCGGAGTTCGGCCGCGACGGGCACGACGGGCCGTTCCGGAAGCCCGTCGGGGACGGTACCCACGCGACCCTCACGGCACCGGCGCGGGCCCGTCCGCTGGTCGGGCCCGCCGTCGCGGACCGCTCCGTCCTCCGCGGCAACTGCCCCGGGCACGGACCGGAAGGGTCCGTTTCGTCCTCGTATCCCTCACCTGTGTGA	MTAFDDGEHHGRYGRREADVREAVSVTAFTAAEFGRDGHDGPFRKPVGDGTHATLTAPARARPLVGPAVADRSVLRGNCPGHGPEGSVSSSYPSPV	MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLGRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW	BGC0000879.1|Toyocamycin/sangivamycin_1#469#759#1#ID=1_1;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.715	gnl|BL_ORD_ID|1335|hsp_num:0	979
BGC0000879.1|Toyocamycin/sangivamycin_17	ID=1_17;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.686	13745	14164	+	Loose	n/a	0.776451	otr(B)	34.15	ARO:3002892, ARO:3003942, ARO:3002893	tcr3, abcA, otr(B)	protein homolog model	n/a	efflux pump complex or subunit conferring antibiotic resistance	efflux pump complex or subunit conferring antibiotic resistance; protein(s) and two-component regulatory system modulating antibiotic efflux	950	25.7942	25.7942, 23.0978, 23.0978	ATGAGCGGTTCCGTCACCCTCGCGTACGACTATCCGCTGCTCGGCGTCTTCTGGACCACGTTCTGGCTCTTCATGTGGGTGCTGTGGTTCTTCCTGCTCTTCCGCGTCATCGGCGACATCTTCCGTGACGACGGGATGAACGGCTGGGCCAAGACCGGCTGGATCCTCTTCGTCCTGGTGCTGCCCTTCCTCGGCGTCCTCGTCTACGTCCTCGCCCGGGGCCGCGGCATGGGCCGGCGCGAGGTGAACCGGGCGCAGGCCCAGCAGGAGGCGTTCGACGCGTACGTACGCCGGACCGCCACGGCGGGCACGCCCCGCGCCACCCCGGCCGACGAGCTGACGAAGCTCTCCCAGCTCAGGGAGCGCGGCGACATCTCGGAGGAGGAGTTCCAGCGGGCGAAGGGCGTGGTCCTGCACTGA	MSGSVTLAYDYPLLGVFWTTFWLFMWVLWFFLLFRVIGDIFRDDGMNGWAKTGWILFVLVLPFLGVLVYVLARGRGMGRREVNRAQAQQEAFDAYVRRTATAGTPRATPADELTKLSQLRERGDISEEEFQRAKGVVLH	MSSANPGPAGTADQAGGAFTHRQILTAMSGLLLAVFLAALDQTVIATAMRTIADDLHGQTEQAWATTGYLIASVLAMPFYGKLSDIYGRKPMYLISIVVFIGGSVLCGTAGSMWELALFRAVQGLGGGGLMSLPTAVVADLAPVRERGRYFAFLQMAWVVASVAGPLAGGFFAEAGQVFGIDGWRWVFLLNVPLGLLALVTVRKALNLPHERREHRMDVLGAAALALFLVPLLIVAEQGRTWGWGSPAALALFALGAAGLAVFIPVELRRGDEAILPLGLFRRGSIALCSAVNFTIGVGIFGTVTTLPLFLQMVQGRTPTQAGLVVIPFMLGTIASQMVSGKLIASSGRFKKLAIVGLGSMAGALLAMATTGATTPMWGIVLIVLWLGVGIGLSQTVITSPMQNSAPKSQLGVANGASGLCRQIGGSTGIAVLFSVMFAVALGRLADLLHTPRYERLLTDPAITGDPANHRFLDMAESGQGAGINLDDTSLLNGIDARLMQPVTDSFAHGFHIMFLAGGVVLLAGFVMTWFLRELQEETAPEEERPAESGAGAKNGPLPASDA	BGC0000879.1|Toyocamycin/sangivamycin_17#13746#14165#1#ID=1_17;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.686	gnl|BL_ORD_ID|1535|hsp_num:0	870
